Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Fixed Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.060.520.520.400.32

What is the latest Fixed Capital/Sales ratio of MANKIND PHARMA ?

The latest Fixed Capital/Sales ratio of MANKIND PHARMA is 1.06 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.06
Mar20240.52
Mar20230.52
Mar20220.40
Mar20210.32

How is Fixed Capital/Sales of MANKIND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.06
103.85
Mar2024 0.52
0.00
Mar2023 0.52
30.00
Mar2022 0.4
25.00
Mar2021 0.32 -

Other Financial Ratios of MANKIND PHARMA


Compare Fixed Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,329.9 Cr -2.3% -4.4% -14.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹105,961.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -3.4% -5.7% 0.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.3%

-4.4%

-14.9%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses